We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?

J Grebely, S Matthews, LM Causer, JJ Feld… - Expert Review of …, 2024 - Taylor & Francis
Introduction Progress toward hepatitis C virus (HCV) elimination is impeded by low testing
and treatment due to the current diagnostic pathway requiring multiple visits leading to loss …

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications

JA Kwon, GJ Dore, B Hajarizadeh, M Alavi, H Valerio… - PLoS …, 2021 - journals.plos.org
Australia was one of the first countries to introduce government-funded unrestricted access
to direct-acting antiviral (DAA) therapy, with 88,790 treated since March 2016. However …

A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

J Grebely, C Markus, LM Causer, D Silk… - The Lancet …, 2023 - thelancet.com
Comment www. thelancet. com/gastrohep Vol 8 March 2023 205 is hampered by current
diagnostic pathways requiring several visits and frequent loss to follow-up, amplified in key …

Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis

STF Shih, Q Cheng, J Carson, H Valerio… - The Lancet Regional …, 2023 - thelancet.com
Background Timely diagnosis and treatment of hepatitis C virus (HCV) is critical to achieve
elimination goals. This study evaluated the cost-effectiveness of point-of-care testing …

Consensus recommendations on the management of hepatitis C in Australia's prisons

RJ Winter, Y Sheehan, T Papaluca… - Medical Journal of …, 2023 - Wiley Online Library
Introduction Prison settings represent the highest concentration of prevalent hepatitis C
cases in Australia due to the high rates of incarceration among people who inject drugs …

The importance of prisons in achieving hepatitis C elimination: insights from the Australian experience

RJ Winter, JA Holmes, TJ Papaluca, AJ Thompson - Viruses, 2022 - mdpi.com
Following the availability of highly effective direct-acting antivirals (DAAs) to treat hepatitis C
infection, the uptake of treatment by people living with hepatitis C rose dramatically in high …

Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: a modelling study

J Stone, AG Lim, GJ Dore, A Borquez… - Liver …, 2023 - Wiley Online Library
Abstract Background & Aims People who inject drugs (PWID) experience high incarceration
rates which are associated with increased hepatitis C virus (HCV) transmission risk. We …

Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020

AL Wilkinson, DK van Santen, MW Traeger… - International Journal of …, 2022 - Elsevier
Background Monitoring trends in hepatitis C virus (HCV) incidence is critical for evaluating
strategies aimed at eliminating HCV as a public health threat. We estimate HCV incidence …

Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study

EM McCartney, L Ralton, J Dawe… - Clinical Infectious …, 2024 - academic.oup.com
Background A barrier to hepatitis C virus (HCV) cure is conventional testing. The aim of this
study was to evaluate the effect of HCV antibody and RNA point-of-care testing (POCT) on …

Becoming posthuman: Hepatitis C, the race to elimination and the politics of remaking the subject

K Seear, E Lenton - Health Sociology Review, 2021 - Taylor & Francis
Hepatitis C has long been a public health problem in Australia.'Revolutionary'new drugs
with the potential to cure hepatitis C have now emerged. The Australian government has …